Page 61 - Read Online

Ryan P, Balis UJ, Tompkins RG, Haber DA, Toner M. Fischer MB. Assessment of a six gene panel for the molecular
Isolation of rare circulating tumour cells in cancer patients by detection of circulating tumor cells in the blood of female
microchip technology. Nature 2007;450:1235-9. cancer patients. BMC Cancer 2010;10:666.
43. Chen CL, Osmulski P, Mahalingum D, Horning AM, 57. Polzer B, Medoro G, Pasch S, Fontana F, Zorzino L, Pestka A,
Jadhav RR, Louie AD, Wang CM, Huang THM. Andergassen U, Meier-Stiegen F, Czyz ZT, Alberter B,
Epithelial-to-mesenchymal markers of circulating tumour cells Treitschke S, Schamberger T, Sergio M, Bregola G, Doffi ni A,
for detection of castration-resistant prostate cancer. Cancer Gianni S, Calanca A, Signorini G, Bolognesi C, Hartmann A,
Res 2014;74:5588. Fasching PA, Sandri MT, Rack B, Fehm T, Giorgini G,
44. Galletti G, Sung MS, Vahdat LT, Shah MA, Santana SM, Manaresi N, Klein CA. Molecular profi ling of single
Altavilla G, Kirby BJ, Giannakakou P. Isolation of breast circulating tumor cells with diagnostic intention. EMBO Mol
cancer and gastric circulating tumour cells by use of an anti Med 2014;6:1371-86.
HER2-based microfl uidic device. Lab Chip 2014;14:147-56. 58. Bredemeier M, Aktas B, Kimmig R, Kasimir-Bauer S.
45. Armstrong AJ, Marengo MS, Oltean S, Kemeny G, Establishment of a multimarker gene panel for the
Bitting RL, Turnbull JD, Herold CI, Marcom PK, George DJ, characterization of circulating tumor cells in metastatic breast
Garcia-Blanco MA. Circulating tumour cells from patients with cancer. Cancer Res 2013;73:1466.
advanced prostate and breast cancer display both epithelial and 59. Mirantes C, Espinosa I, Ferrer I, Dolcet X, Prat J,
mesenchymal markers. Mol Cancer Res 2011;9:997-1007. Matias-Guiu X. Epithelial-tomesenchymal transition and stem
46. Smirnov DA, Zweitzig DR, Foulk BW, Miller MC, Doyle GV, cells in endometrial cancer. Hum Pathol 2013;44:1973-81.
Pienta KJ, Meropol NJ, Weiner LM, Cohen SJ, Moreno JG, 60. Wik E, Ræder MB, Krakstad C, Trovik J, Birkeland E,
Connelly MC, Terstappen LW, O’Hara SM. Global gene Hoivik EA, Mjos S, Werner HM, Mannelqvist M,
expression profi ling of circulating tumour cells. Cancer Res Stefansson IM, Oyan AM, Kalland KH, Akslen LA,
2005;65:4993-7. Salvesen HB. Lack of estrogen receptor-α is associated with
47. Williams A, Rawal S, Ao Z, Lu B, Toress-Munoz J, Rini B, epithelial-mesenchymal transition and PI3K alterations in
Pelley R, Budd GT, Borden E, Zheng S, Datar R, Tai YC, endometrial carcinoma. Clin Cancer Res 2013;19:1094-105.
Cote R. Capture and molecular characterization of CTC in 61. Powell AA, Talasaz AH, Zhang H, Coram MA, Reddy A,
metastatic breast, prostate, colorectal and renal cancer. Cancer Deng G, Telli ML, Advani RH, Carlson RW, Mollick JA,
Res 2012;72:2372. Sheth S, Kurian AW, Ford JM, Stockdale FE, Quake SR,
48. Haber DA, Maheshwaran S, Sequist L, Yu M, Ozkummur E, Pease RF, Mindrinos MN, Bhanot G, Dairkee SH, Davis RW,
Jeffrey SS. Single cell profi ling of circulating tumour cells:
Ting D, Miyamoto D, Lee R, Shah A, Bardia A, Stott S, transcriptional heterogeneity and diversity from breast cancer
Toner M. Molecular characterization of circulating tumour cell lines. PLoS One 2012;7:e33788.
cells. Mol Cancer Ther 2013;12:PL06-04. (Abstract).
49. Schölch S, Bork U, Rahbari NN, García S, Swiersy A, 62. Königsberg R, Obermayr E, Bises G, Pfeiler G, Gneist M,
Wrba F, de Santis M, Zeillinger R, Hudec M, Dittrich C.
Betzler AM, Weitz J, Koch M. Circulating tumor cells of Detection of EpCAM positive and negative circulating tumor cells
colorectal cancer. Cancer Cell Microenviron 2014;1:e323. in metastatic breast cancer patients. Acta Oncol 2011;50:700-10.
50. Aceto N, Bardia A, Miyamoto DT, Donaldson MC, 63. Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R,
Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, Kanz L. Mobilization of tumor cells and hematopoietic
Brannigan BW, Kapur R, Stott SL, Shioda T, Ramaswamy S, progenitor cells into peripheral blood of patients with solid
Ting DT, Lin CP, Toner M, Haber DA, Maheswaran S. tumor. Blood 1994;83:636-40.
Circulating tumour cell clusters are oligoclonal precursors of 64. Peeters DJ, van Dam PJ, Van den Eynden GG, Rutten A,
breast cancer metastasis. Cell 2014;158:1110-22. Wuyts H, Pouillon L, Peeters M, Pauwels P, Van Laere SJ,
51. Bidard FC, Vincent-Salomon A, Sigal-Zafrani B, Diéras V, van Dam PA, Vermeulen PB, Dirix LY. Detection and
Mathiot C, Mignot L, Thiery JP, Sastre-Garau X, Pierga JY. prognostic signifi cance of circulating tumour cells in
Prognosis of women with stage IV breast cancer depends on patients with metastatic breast cancer according to
detection of circulating tumour cells rather than disseminated immunohistochemical subtypes. Br J Cancer 2014;110:375-83.
tumour cells. Ann Oncol 2008;19:496-500. 65. Smerage JB, Barlow WE, Hortobagyi GN, Winer EP,
52. Rack B, Schindlbeck C, Jückstock J, Andergassen U, Leyland-Jones B, Srkalovic G, Tejwani S, Schott AF,
Hepp P, Zwingers T, Friedl TW, Lorenz R, Tesch H, O’Rourke MA, Lew DL, Doyle GV, Gralow JR,
Fasching PA, Fehm T, Schneeweiss A, Lichtenegger W, Livingston RB, Hayes DF. Circulating Tumor cells and
Beckmann MW, Friese K, Pantel K, Janni W; SUCCESS response to chemotherapy in metastatic breast cancer: SWOG
Study Group. Circulating tumor cells predict survival in early S0500. J Clin Oncol 2014;256:251.
average-to-high risk breast cancer patients. J Natl Cancer Inst 66. Martelotto LG, Ng CK, Piscuoglio S, Weigelt B, Reis-Filho JS.
2014;106:dju066. Breast cancer intra-tumor heterogeneity. Breast Cancer Res
53. Lianidou ES, Markou A. Ciculating tumour cells in breast 2014;16:210.
cancer: Detection systems, molecular characterization, and 67. Dittamore R, Louw J, Krupa R, Anand A, Danila DC, ArslanZ,
future challenges. Clin Chem 2011;57:1242-55. Bales N, Marrinucci D, Scher HI. Molecular characteriszation
54. Fernandez SV, Bingham C, Fittipaldi P, Austin L, Palazzo J, of circulating tumour cells (CTC) and CTC subpopulations in
Palmer G, Alpaugh K, Cristofanilli M. TP53 mutations baseline and progressive metastatic castration resistant prostate
detected in circulating tumour cells present in the blood of cancer (mCRPC). J Clin Oncol 2014;32:abstr e16018.
metastatic triple negative breast cancer patients. Breast Cancer 68. Hoogland AM, Kweldam CF, van Leenders GJ. Prognostic
Res 2014;16:445. histopathological and molecular markers on prostate cancer
55. Swaby RF, Cristofanilli M. Circulating tumor cells in breast needle-biopsies: a review. Biomed Res Int 2014;2014:341324.
cancer: a tool whose time has come of age. BMC Med 69. Miyamoto DT, Lee RJ, Stott SL, Ting DT, Wittner BS,
2011;9:43. Ulman M, Smas ME, Lord JB, Brannigan BW, Trautwein J,
56. Obermayr E, Sanchez-Cabo F, Tea MM, Singer CF, Krainer M, Bander NH, Wu CL, Sequist LV, Smith MR, Ramaswamy S,

54 Journal of Cancer Metastasis and Treatment ¦ Volume 1 ¦ Issue 2 ¦ July 15, 2015 ¦